Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endoscopic Complications Following EUS-B Fine-Needle Aspiration Performed by Interventional Pulmonologists: Incidence, Characteristics, and Prospective Cohort Analysis.

Journal of bronchology & interventional pulmonology·2026
Same author

Mechanistic Insights Into Nitric Oxide Capture and Release in a Radical-Scavenging Zinc Ascorbate Metal-Organic Framework.

Small science·2026
Same author

Microscale hemoglobin assay for time-resolved kinetic analysis of nitric oxide release from electrospun hydrogels.

Analytica chimica acta·2026
Same author

Assessing N. gonorrhoeae prevalence and testing capacity for new treatment rollout: a scoping review for Cambodia, Thailand, Vietnam and South Africa.

BMC infectious diseases·2026
Same author

Effect of anti-tuberculosis drugs on the pharmacokinetics and pharmacodynamics of novel antidiabetic drugs: A scoping review.

Pulmonology·2026
Same author

ERS Congress 2025: highlights from the Respiratory Infections Assembly.

ERJ open research·2026
Same journal

Intraoperative endoscopic detection of multiple ciliary body cysts not detected preoperatively.

BMJ case reports·2026
Same journal

Can focal nodular hyperplasia transform into hepatocellular carcinoma? A 20-year journey from benign to malignant.

BMJ case reports·2026
Same journal

Isolated jejunal tuberculosis presenting as chronic intestinal obstruction.

BMJ case reports·2026
Same journal

Revision of diagnosis in a child with type 1 diabetes mellitus due to appropriate genetic testing - Wolfram Syndrome.

BMJ case reports·2026
Same journal

Bilateral corneal perforation following post-PRK fungal keratitis managed with tenons patch graft.

BMJ case reports·2026
Same journal

Early onset cerebral oedema in adult diabetic ketoacidosis with complete resolution.

BMJ case reports·2026
See all related articles

Related Experiment Videos

Post liver transplant tuberculosis.

Luis Vaz Rodrigues1, Judit Gandara, João Pires

  • 1Centro Hospitalar de Coimbra, Pulmunology, Quinta dos Vales, S. Martinho do Bispo, Coimbra, 3041-801, Portugal.

BMJ Case Reports
|August 18, 2011
PubMed
Summary
This summary is machine-generated.

This study highlights a liver transplant patient with disseminated tuberculosis who experienced elevated liver enzymes during anti-tuberculosis drug treatment. Careful management of immunosuppressants allowed continued tuberculosis therapy without adverse effects.

Related Experiment Videos

Area of Science:

  • Hepatology
  • Transplant Surgery
  • Infectious Diseases

Background:

  • Liver transplant recipients often require immunosuppression, increasing susceptibility to opportunistic infections like tuberculosis.
  • Disseminated tuberculosis (hepatic and pulmonary) presents a significant management challenge in post-transplant patients.

Purpose of the Study:

  • To describe the clinical course and management of a liver transplant patient with disseminated tuberculosis.
  • To investigate the cause of elevated liver enzymes during anti-tuberculosis treatment in an immunosuppressed patient.

Main Methods:

  • Case report detailing the diagnosis and treatment of disseminated tuberculosis in a liver transplant recipient.
  • Monitoring of liver enzymes and immunosuppressant drug levels.
  • Adjustment of immunosuppressive therapy in response to drug-induced liver injury.

Main Results:

  • The patient presented with disseminated tuberculosis (hepatic and pulmonary) post-liver transplant.
  • Elevated liver enzymes were observed during anti-tuberculosis drug administration, initially suspected as graft rejection but later attributed to drug toxicity.
  • Close monitoring and adjustment of immunosuppressant drug levels enabled the continuation of tuberculosis treatment.

Conclusions:

  • Drug-induced liver injury is a critical consideration in immunosuppressed patients undergoing tuberculosis treatment.
  • Careful management, including drug level monitoring and immunosuppression adjustment, is essential for successful co-treatment of tuberculosis and post-transplant care.
  • This case underscores the importance of vigilant monitoring for adverse drug reactions in complex post-transplant scenarios.